2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide

C29H39N3O3 — CID 25195783

IUPAC2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide
SMILESCn1c2c(c3cc(C(=O)N4CCCC(NC(=O)CC5CC5)C4)ccc31)CC(C1CCOCC1)CC2
InChIInChI=1S/C29H39N3O3/c1-31-26-8-6-21(20-10-13-35-14-11-20)16-24(26)25-17-22(7-9-27(25)31)29(34)32-12-2-3-23(18-32)30-28(33)15-19-4-5-19/h7,9,17,19-21,23H,2-6,8,10-16,18H2,1H3,(H,30,33)
InChIKeyPVXLTSMFPOEQGA-UHFFFAOYSA-N
MW477.65 g/mol
LogP4.23
Rot. Bonds5

About 2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide

2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide (PubChem CID 25195783) has the molecular formula C29H39N3O3 and a molecular weight of 477.65 g/mol. Its IUPAC name is 2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide.

Molecular Properties

Compound Name2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide
PubChem CID25195783
Molecular FormulaC29H39N3O3
Molecular Weight477.65 g/mol
Exact Mass477.30
IUPAC Name2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide
SMILESCn1c2c(c3cc(C(=O)N4CCCC(NC(=O)CC5CC5)C4)ccc31)CC(C1CCOCC1)CC2
InChIInChI=1S/C29H39N3O3/c1-31-26-8-6-21(20-10-13-35-14-11-20)16-24(26)25-17-22(7-9-27(25)31)29(34)32-12-2-3-23(18-32)30-28(33)15-19-4-5-19/h7,9,17,19-21,23H,2-6,8,10-16,18H2,1H3,(H,30,33)
InChIKeyPVXLTSMFPOEQGA-UHFFFAOYSA-N
XLogP4.23
TPSA63.57 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500477.65
LogP ≤ 54.23
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}

Analyze 2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide?
The IUPAC name of 2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide (CID 25195783) is 2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide.
What is the SMILES notation for 2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide?
The canonical SMILES for 2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide is Cn1c2c(c3cc(C(=O)N4CCCC(NC(=O)CC5CC5)C4)ccc31)CC(C1CCOCC1)CC2.
What is the InChIKey of 2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide?
The InChIKey is PVXLTSMFPOEQGA-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H39N3O3/c1-31-26-8-6-21(20-10-13-35-14-11-20)16-24(26)25-17-22(7-9-27(25)31)29(34)32-12-2-3-23(18-32)30-28(33)15-19-4-5-19/h7,9,17,19-21,23H,2-6,8,10-16,18H2,1H3,(H,30,33).
What are the key properties of 2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide?
2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide has a molecular weight of 477.65 g/mol, XLogP of 4.23, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclopropyl-N-[1-[9-methyl-6-(oxan-4-yl)-5,6,7,8-tetrahydrocarbazole-3-carbonyl]piperidin-3-yl]acetamide is sourced from PubChem (CID 25195783), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).